These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35727527)

  • 1. The Influence of Non-E. Coli or Extended-Spectrum β-Lactamase-Producing Bacterial Growth on the Follow-Up Procedure of Infants with the First Febrile Urinary Tract Infection.
    Kavruk M; Soyaltın E; Erfidan G; Arslansoyu Çamlar S; Alaygut D; Mutlubaş F; Yılmaz N; Kasap Demir B
    Indian J Pediatr; 2023 Jul; 90(7):677-682. PubMed ID: 35727527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria.
    Soyaltın E; Erfidan G; Kavruk M; Çamlar SA; Yılmaz N; Alaygut D; Mutlubaş F; Demir BK
    Turk J Pediatr; 2022; 64(2):265-273. PubMed ID: 35611415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tract infections owing to ESBL-producing bacteria: microorganisms change--clinical pattern does not.
    Özçakar ZB; Yalçınkaya F; Kavaz A; Kadıoğlu G; Elhan AH; Aysev D; Güriz H; Ekim M
    Acta Paediatr; 2011 Aug; 100(8):e61-4. PubMed ID: 21392102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
    Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
    Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase
    Vachvanichsanong P; McNeil EB; Dissaneewate P
    Epidemiol Infect; 2020 Dec; 149():e12. PubMed ID: 33327984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
    Abe Y; Inan-Erdogan I; Fukuchi K; Wakabayashi H; Ogawa Y; Hibino S; Sakurai S; Matsuhashi K; Watanabe Y; Hashimoto K; Ugajin K; Itabashi K
    J Infect Chemother; 2017 Aug; 23(8):517-522. PubMed ID: 28528936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Extended-Spectrum β-Lactamase-Producing Pathogens in Community-Acquired Urinary Tract Infections Among Infants at a Pediatric Emergency Department.
    Tamas V; Shah S; Hollenbach KA; Kanegaye JT
    Pediatr Emerg Care; 2022 Mar; 38(3):e1053-e1057. PubMed ID: 35226630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
    Ohnishi T; Mishima Y; Takizawa S; Tsutsumi K; Amemiya A; Akiyama N; Kanna Y; Asato S; Tomita M; Ikemiyagi M; Shikoro N; Nakazawa M; Kurihara N; Kamimaki I
    Keio J Med; 2020 Jun; 69(2):43-47. PubMed ID: 31474677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
    Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
    Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
    Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM
    J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli.
    Jo KJ; Yoo S; Song JY; Kim SH; Park SE
    Pediatr Neonatol; 2021 May; 62(3):271-277. PubMed ID: 33602619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.
    Ruppé E; Lixandru B; Cojocaru R; Büke C; Paramythiotou E; Angebault C; Visseaux C; Djuikoue I; Erdem E; Burduniuc O; El Mniai A; Marcel C; Perrier M; Kesteman T; Clermont O; Denamur E; Armand-Lefèvre L; Andremont A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4512-7. PubMed ID: 23836184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.
    Collingwood JD; Wang L; Aban IB; Yarbrough AH; Boppana SB; Dangle PP
    J Pediatr Urol; 2023 Feb; 19(1):129.e1-129.e7. PubMed ID: 36344365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants.
    Kim YH; Yang EM; Kim CJ
    J Pediatr (Rio J); 2017; 93(3):260-266. PubMed ID: 27842212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of extended-spectrum beta-lactamase producing E. coli causing urinary tract infections in Iceland during 2012-2021.
    Halldórsdóttir AM; Hrafnkelsson B; Einarsdóttir K; Kristinsson KG
    Eur J Clin Microbiol Infect Dis; 2024 Sep; 43(9):1689-1697. PubMed ID: 38935227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern.
    Collingwood JD; Yarbrough AH; Boppana SB; Dangle PP
    Pediatr Infect Dis J; 2023 Feb; 42(2):106-109. PubMed ID: 36638394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.